Viral encephalitis

Summary

Viral encephalitis (MONDO:0006009) is a disease (an umbrella term covering 12 Mondo subtypes) and 2 clinical trials. A subtype of infectious encephalitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 12 Mondo subtypes
• Clinical trials: 2

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	viral encephalitis
Mondo ID	MONDO:0006009
EFO	EFO:0007538
Orphanet	98252
DOID	DOID:646
NCIT	C35302
SNOMED CT	34476008
UMLS	C0243010
MedGen	116719
GARD	0019433
MedDRA	10058805
Is cancer (heuristic)	no

Also known as: viral encephalitis · Viruses caused encephalitis · Viruses encephalitis

Disease family

This is a subtype of infectious encephalitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › encephalomyelitis › encephalitis › infectious encephalitis › viral encephalitis

Related subtypes (9): primary amebic meningoencephalitis, granulomatous amebic encephalitis, syphilitic encephalitis, Kluver-Bucy syndrome, progressive multifocal leukoencephalopathy, acute necrotizing encephalopathy of childhood, Hendra virus infection, Mycoplasma encephalitis, postinfectious encephalitis

Subtypes (12): Powassan encephalitis, acute necrotizing encephalitis, acute hemorrhagic encephalitis, Colorado tick fever, eastern equine encephalitis, subacute sclerosing panencephalitis, herpes simplex encephalitis, tick-borne encephalitis, encephalitis lethargica, mosquito-borne viral encephalitis, HHV-6 encephalitis, borna virus encephalitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 2.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE2	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT02479698	PHASE2	RECRUITING	Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
NCT07186881	Not specified	ENROLLING_BY_INVITATION	Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis